2,4-Dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid monohydrate

Acta Crystallographica Section E: Structure Reports Online

Volumn 60, Issue 6, 2004, Pages

  Law, Ga Lai ^a   Szeto, Lap ^a   Wong, Wing Tak ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; CARBOXYLIC ACIDS; CRYSTAL STRUCTURE; DERIVATIVES; DRUG PRODUCTS; ENZYME INHIBITION; ESTERS; FURAN RESINS; HYDROGEN BONDS; WATER;

ANTITHYROID DRUGS; FUNCTIONAL GROUPS; TETRAHYDROFURANS (THF); URACIL COMPOUNDS;

AROMATIC COMPOUNDS;

EID: 18444391503     PISSN: 16005368     EISSN: 16005368     Source Type: Journal    
DOI: 10.1107/S1600536804012267     Document Type: Article

References (10)

1. Bruker (1998). SMART. Version 5.059. Bruker AXS Inc., Madison, Wisconsin, USA.
2. Bruker (1999). SAINT. Version 6.01. Bruker AXS Inc., Madison, Wisconsin, USA.
3. Farrugia, L. J. (2001). ORTEP-3 for Windows. Version 1.075. University of Glasgow, Scotland,
4. Gosh, C., Schmidt, D. G. & Pal, B. C. (1984). J. Org. Chem. 49, 5256-5257.
5. Iltzsch, M. H. & Tankersley, K. O. (1994). Biochem. Pharmacol. 48, 781-791.
6. Javaid, Z. Z., el Kouni, M. H. & Iltzsch, M. H. (1999). Biochem. Pharmacol. 58, 1457-1465.
7. Pal, B. C. (1978). J. Am. Chem. Soc. 100, 5170-5174.
8. Rigaku/MSC (2003). CrystalStructure. Version 3.5.1. Rigaku/MSC, 9009 New Trails Drive, The Woodlands, TX 77381, USA.
9. Sheldrick, G. M. (1997). SHELXS97. University of Göttingen, Germany.
10. Watkin, D. J., Prout, C. K. Carruthers, J. R. & Betteridge, P. W. (1996). CRYSTALS.Issue 10. Chemical Crystallography Lab., Oxford, England.